Source: MarketScreener

Soligenix: Soligenix Invited to Present at Upcoming Virtual Investor Conferences

(marketscreener.com) PRINCETON, N.J., Sept. 9, 2020 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its President and Chief Executive Officer, Christopher J. Schaber, PhD, will deliver a corporate...https://www.marketscreener.com/news/latest/Soligenix-Invited-to-Present-at-Upcoming-Virtual-Investor-Conferences--31257296/?utm_medium=RSS&utm_content=20200909

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Christopher J. Schaber's photo - President & CEO of Soligenix

President & CEO

Christopher J. Schaber

CEO Approval Rating

68/100

Soligenix develops and commercializes biotherapeutics for the treatment of gastrointestinal disorders, inflammation and oncology diseases. Read more